Zyla Life Sciences (EGLT) Return on Investment ROI from the first quarter of 2020 to first quarter of 2019 and for the year 2020, average high and low, overall ranking from Mar 31 2020 to Mar 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Zyla Life Sciences  (EGLT)


Zyla Life Sciences's ROI from its first quarter of 2020 to the first quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zyla Life Sciences's ROI in the first quarter of 2020?
Zyla Life Sciences recorded a cumulative net loss of $-101 million during 12 months ending in the first quarter of 2020, resulting in a negative return on investment (ROI) of -64.85%.

Within the Healthcare sector 542 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2019 from 0 to 3947.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Investment Change TTM - 944.62 % 278.98 % -62.07 % -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 136 155 163 171 -5
Return On Investment (TTM) -64.85 % -78.96 % -69.55 % -395.48 % -
EGLT's Overall Ranking # 3947 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 29.26 % 35.17 % 242.94 % - -
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -101 -95 -62 -103 -95

EGLT Company Profile >> Back to EGLT Roi Comparisons >> See Annual EGLT Return On Investment



Return On Investment EGLT's Ranking
Within: No.
Industry # 251
Sector # 543
Overall # 3947

Return On Investment Statistics
High Average Low
-34.29 %
-88.23 %
-314.02 %
(Sep 30 2019)   (Sep 30 2018)







Financial Statements
Zyla Life Sciences's I. Quarter Investments $ 136 Millions EGLT's Balance sheet
Zyla Life Sciences's I. Quarter Income $ -18 Millions Quarterly EGLT's Income Statement
EGLT's Income by Division See EGLT's Income by Division


EGLT Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 155 29 77 90 144
Y / Y Investment Growth 437.08 % -62.56 % -14.53 % -37.42 % 170.51 %
Net Income in Millions -95 -95 -69 -91 -58
Y / Y Net Income Growth - - - - -
Annual Return On Investment -61.74 % -331.58 % -90.2 % -100.74 % -40.3 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EGLT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EGLT's Competitors
Subscribers only: Roi for Zyla Life Sciences's Suppliers
Subscribers only: Return On Investment for EGLT's Customers

Other Ratios
EGLT's Roa EGLT's Inventory Turnover Ratio EGLT's Growth Rates EGLT's Dividend Statistics
EGLT's Profitability Ratios EGLT's Asset Turnover Ratio EGLT's Dividend Growth
EGLT's Roe EGLT's Valuation Ratios EGLT's Financial Strength Ratios EGLT's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:09:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.